Chemcrux Enterprises Ltd

Chemcrux Enterp. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Chemcrux Enterprises Ltd

₹ 91.6 -1.47%
15 May - close price
chemcrux.com BSE: 540395
About

Incorporated in 1996, Chemcrux Enterprises Ltd manufactures and processes bulk drug intermediates[1]

Key Points

Business Overview:[1]
CEL is an ISO 9001:2015, ISO 14001:2015 and ISO 50001:2018 certified company. It specializes in High Pressure Oxidation, Nitration, Chlorosulfonation and Amidation Chemistry - manufacturing intermediates
for bulk drugs(API), dyes & pigment, electro-plating, pharmaceuticals, dyes and pigments industries

Website BSE
  • Market Cap ₹ 136 Cr.
  • Current Price ₹ 91.6
  • High / Low ₹ 159 / 64.0
  • Stock P/E 36.4
  • Book Value ₹ 51.9
  • Dividend Yield 1.09 %
  • ROCE 7.40 %
  • ROE 4.93 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has been maintaining a healthy dividend payout of 31.7%

Cons

  • Company has a low return on equity of 7.21% over last 3 years.
  • Working capital days have increased from 56.8 days to 87.1 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
20.01 22.29 15.84 21.81 18.54 17.11 17.76 19.42 15.72 16.50 17.75 22.11 24.28
14.90 18.43 13.50 17.43 15.92 15.05 15.40 16.73 13.61 14.87 15.96 18.58 20.10
Operating Profit 5.11 3.86 2.34 4.38 2.62 2.06 2.36 2.69 2.11 1.63 1.79 3.53 4.18
OPM % 25.54% 17.32% 14.77% 20.08% 14.13% 12.04% 13.29% 13.85% 13.42% 9.88% 10.08% 15.97% 17.22%
0.18 0.18 0.24 0.56 0.35 0.39 0.26 0.61 0.24 0.44 0.63 0.60 0.36
Interest 0.47 0.31 0.21 0.17 0.13 0.13 0.33 0.60 0.69 0.86 0.83 0.76 0.70
Depreciation 0.58 0.57 0.58 0.58 0.55 0.56 0.73 0.92 0.99 1.18 1.20 1.19 1.17
Profit before tax 4.24 3.16 1.79 4.19 2.29 1.76 1.56 1.78 0.67 0.03 0.39 2.18 2.67
Tax % 31.13% 26.27% 30.17% 36.75% 3.49% 29.55% 26.28% 25.84% 68.66% -233.33% 46.15% 27.98% 30.71%
2.92 2.33 1.24 2.66 2.21 1.24 1.15 1.32 0.21 0.09 0.21 1.58 1.85
EPS in Rs 1.97 1.57 0.84 1.80 1.49 0.84 0.78 0.89 0.14 0.06 0.14 1.07 1.25
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
95.27 95.15 78.47 70.01 80.65
74.56 73.69 65.10 60.78 69.50
Operating Profit 20.71 21.46 13.37 9.23 11.15
OPM % 21.74% 22.55% 17.04% 13.18% 13.83%
1.00 1.05 1.18 1.49 2.02
Interest 0.17 0.82 0.83 1.75 3.15
Depreciation 1.59 2.04 2.29 3.21 4.73
Profit before tax 19.95 19.65 11.43 5.76 5.29
Tax % 25.51% 26.92% 26.16% 32.12% 29.30%
14.86 14.36 8.44 3.91 3.73
EPS in Rs 10.03 9.70 5.70 2.64 2.52
Dividend Payout % 19.93% 20.63% 17.55% 37.88% 39.71%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: -5%
TTM: 15%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -36%
TTM: 1%
Stock Price CAGR
10 Years: %
5 Years: -1%
3 Years: -36%
1 Year: -38%
Return on Equity
10 Years: %
5 Years: 13%
3 Years: 7%
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 14.81 14.81 14.81 14.81 14.81
Reserves 39.87 51.60 57.45 59.81 62.04
9.75 14.43 26.46 42.30 34.37
19.34 12.38 11.15 10.13 16.22
Total Liabilities 83.77 93.22 109.87 127.05 127.44
25.49 33.11 33.09 77.06 74.96
CWIP 0.00 0.31 21.06 1.61 4.08
Investments 7.08 16.79 19.83 19.83 15.93
51.20 43.01 35.89 28.55 32.47
Total Assets 83.77 93.22 109.87 127.05 127.44

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
9.16 14.82 16.34 7.59 13.85
-2.64 -20.48 -25.89 -2.48 -0.07
3.96 0.96 7.64 -9.16 -12.36
Net Cash Flow 10.49 -4.70 -1.91 -4.04 1.42
Free Cash Flow 4.59 3.71 -6.85 -0.64 8.74
CFO/OP 69% 86% 142% 98% 136%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 72.33 51.56 71.17 61.42 85.58
Inventory Days 92.33 124.92 99.63 135.16 68.51
Days Payable 92.57 71.19 70.84 60.56 104.17
Cash Conversion Cycle 72.09 105.28 99.96 136.01 49.92
Working Capital Days 37.43 67.28 55.49 27.94 87.08
ROCE % 27.63% 13.46% 6.69% 7.40%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Total Permanent Employees
Number ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Total Research & Development (R&D) Spend
Rs. Lakhs ・Standalone data
Actual Production Volume (Oxidation, Nitration, Chloro Sulfonation)
MT ・Standalone data
Total Installed Capacity (Oxidation, Nitration, Chloro Sulfonation)
MT/Year ・Standalone data
Total Reaction Capability
KL ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
72.94% 72.92% 72.92% 72.92% 72.92% 72.92% 72.92% 72.92% 72.92% 72.92% 72.92% 72.92%
27.07% 27.07% 27.06% 27.09% 27.08% 27.07% 27.07% 27.07% 27.07% 27.07% 27.08% 27.09%
No. of Shareholders 30,67032,55932,15930,94628,97727,36526,21925,25024,35323,47822,59321,727

Documents

Announcements

Annual reports

DRHP